Thermo Fisher Scientific Stock Alpha and Beta Analysis
| TMO Stock | USD 611.92 11.99 1.92% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Thermo Fisher Scientific. It also helps investors analyze the systematic and unsystematic risks associated with investing in Thermo Fisher over a specified time horizon. Remember, high Thermo Fisher's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Thermo Fisher's market risk premium analysis include:
Beta 0.89 | Alpha 0.0816 | Risk 1.24 | Sharpe Ratio 0.16 | Expected Return 0.2 |
Thermo Fisher Quarterly Cash And Equivalents |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Thermo Fisher Backtesting, Thermo Fisher Valuation, Thermo Fisher Correlation, Thermo Fisher Hype Analysis, Thermo Fisher Volatility, Thermo Fisher History and analyze Thermo Fisher Performance. Thermo Fisher Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Thermo Fisher market risk premium is the additional return an investor will receive from holding Thermo Fisher long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Thermo Fisher. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Thermo Fisher's performance over market.| α | 0.08 | β | 0.89 |
Thermo Fisher expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Thermo Fisher's Buy-and-hold return. Our buy-and-hold chart shows how Thermo Fisher performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Thermo Fisher Market Price Analysis
Market price analysis indicators help investors to evaluate how Thermo Fisher stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Thermo Fisher shares will generate the highest return on investment. By understating and applying Thermo Fisher stock market price indicators, traders can identify Thermo Fisher position entry and exit signals to maximize returns.
| Price Series Summation | ||
| Price Series Division | ||
| Inverse Tangent Over Price Movement | ||
| Price Ceiling Movement | ||
| Aroon Oscillator | ||
| Balance Of Power | ||
| All Moving Average | ||
| MESA Adaptive Moving Average | ||
| Belt hold | ||
| Hanging Man |
Thermo Fisher Return and Market Media
The median price of Thermo Fisher for the period between Thu, Oct 30, 2025 and Wed, Jan 28, 2026 is 579.45 with a coefficient of variation of 3.77. The daily time series for the period is distributed with a sample standard deviation of 22.08, arithmetic mean of 585.89, and mean deviation of 17.93. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Thermo Fisher Scientific Launches CorEvitas Obesity Registry to Advance Real-World Evidence in Treatment Outcomes | 01/06/2026 |
2 | Viega North America Names Dave DeLater Chief Operating Officer | 01/12/2026 |
| Thermo Fisher dividend paid on 15th of January 2026 | 01/15/2026 |
4 | Custom Antibody Market to Reach USD 1,297.65 Million by 2033, Growing Demand for Precision Medicine and Targeted Therapies to Drive the Market SNS Insider | 01/20/2026 |
5 | Pharmaceutical Contract Manufacturing Organization Market Analysis Report 2026-2031 - Biologics Drive Major Investments as Complexity and Demand Rise | 01/21/2026 |
6 | Thermo Fishers AI Lab Push And Leadership Shift Might Change The Case For Investing In TMO | 01/22/2026 |
7 | mRNA Therapeutics Contract Development Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 | 01/23/2026 |
8 | Countdown to Thermo Fisher Q4 Earnings A Look at Estimates Beyond Revenue and EPS | 01/26/2026 |
About Thermo Fisher Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Thermo or other stocks. Alpha measures the amount that position in Thermo Fisher Scientific has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 | 2025 | 2026 (projected) | Dividend Yield | 0.002553 | 0.002934 | 0.003374 | 0.003205 | Price To Sales Ratio | 4.78 | 4.63 | 4.17 | 4.38 |
Thermo Fisher Upcoming Company Events
As portrayed in its financial statements, the presentation of Thermo Fisher's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Thermo Fisher's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Thermo Fisher's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Thermo Fisher. Please utilize our Beneish M Score to check the likelihood of Thermo Fisher's management manipulating its earnings.
| 31st of January 2024 Upcoming Quarterly Report | View | |
| 24th of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 31st of January 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Thermo Fisher
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Thermo Fisher Backtesting, Thermo Fisher Valuation, Thermo Fisher Correlation, Thermo Fisher Hype Analysis, Thermo Fisher Volatility, Thermo Fisher History and analyze Thermo Fisher Performance. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Thermo Fisher technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.